Irbesartan Vocate (Irbesartan)

Irbesartan selectively blocks AT1 receptors for angiotensin II, preventing the hormone from causing vasoconstriction and stimulating aldosterone release. This results in relaxed blood vessels, lower peripheral resistance, reduced sodium and water retention, and ultimately a decrease in blood pressure and renal protection.

The specific dose of Irbesartan Vocate is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Irbesartan is generally not recommended during pregnancy because it may affect fetal development. Safety during breastfeeding has not been fully established, so the prescriber will weigh potential benefits against risks before recommending use in these situations.

To place an order, submit an enquiry on the Irbesartan Vocate product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure reduction similar to ACE inhibitors but with a lower incidence of cough. Compared with calcium‑channel blockers or diuretics, ARBs provide a distinct mechanism by blocking angiotensin II, making them useful when other classes are contraindicated or not tolerated.

Irbesartan Vocate should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Irbesartan Vocate is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider and not crush or split the tablet unless instructed.

Serious risks include angioedema (swelling of the face, lips, tongue, or airway), severe hypotension, acute kidney injury, and hyperkalemia. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden drop in blood pressure, or signs of kidney dysfunction.

Irbesartan Vocate is contraindicated in patients with known hypersensitivity to irbesartan or any ARB component. It should also be avoided in individuals with severe hepatic impairment and in pregnant women unless the benefits outweigh the risks. Patients with certain kidney conditions may require close monitoring or alternative therapy.